Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124161082 | 12416108 | 2 | F | 20160919 | 20160530 | 20160923 | PER | US-PFIZER INC-2016259297 | PFIZER | 72.00 | YR | F | Y | 0.00000 | 20160923 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124161082 | 12416108 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 25 MG, DAILY (EVERY DAY) | 298AA | 21938 | 25 | MG | CAPSULE, HARD | ||||||
124161082 | 12416108 | 2 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
124161082 | 12416108 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | 10 MG, UNK | 0 | 10 | MG | TABLET | ||||||||
124161082 | 12416108 | 4 | C | WARFARIN | WARFARIN | 1 | 2.5 MG, UNK | 0 | 2.5 | MG | TABLET | ||||||||
124161082 | 12416108 | 5 | C | DRONABINOL. | DRONABINOL | 1 | 2.5 MG, UNK | 0 | 2.5 | MG | CAPSULE | ||||||||
124161082 | 12416108 | 6 | C | PREDNISONE. | PREDNISONE | 1 | 10 MG, UNK | 0 | 10 | MG | TABLET | ||||||||
124161082 | 12416108 | 7 | C | INDAPAMIDE. | INDAPAMIDE | 1 | 1.25 MG, UNK | 0 | 1.25 | MG | TABLET | ||||||||
124161082 | 12416108 | 8 | C | LUNESTA | ESZOPICLONE | 1 | 3 MG, UNK | 0 | 3 | MG | TABLET | ||||||||
124161082 | 12416108 | 9 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 15 MG, UNK | 0 | 15 | MG | TABLET | ||||||||
124161082 | 12416108 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, UNK | 0 | 20 | MG | TABLET | ||||||||
124161082 | 12416108 | 11 | C | BUMETANIDE. | BUMETANIDE | 1 | UNK | 0 | |||||||||||
124161082 | 12416108 | 12 | C | GLEEVEC | IMATINIB MESYLATE | 1 | 400 MG, UNK | 0 | 400 | MG | TABLET | ||||||||
124161082 | 12416108 | 13 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 30 MG, UNK | 0 | 30 | MG | CAPSULE | ||||||||
124161082 | 12416108 | 14 | C | ATENOLOL. | ATENOLOL | 1 | 25 MG, UNK | 0 | 25 | MG | TABLET | ||||||||
124161082 | 12416108 | 15 | C | LEVOTHYROXIN | LEVOTHYROXINE | 1 | 137 UG, UNK | 0 | 137 | UG | TABLET | ||||||||
124161082 | 12416108 | 16 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 10 MG, UNK | 0 | 10 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124161082 | 12416108 | 1 | Neoplasm malignant |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124161082 | 12416108 | Abdominal distension | |
124161082 | 12416108 | Dry skin | |
124161082 | 12416108 | Fatigue | |
124161082 | 12416108 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124161082 | 12416108 | 1 | 201404 | 0 |